Literature DB >> 10582669

Resection and permanent I-125 brachytherapy without whole brain irradiation for solitary brain metastasis from non-small cell lung carcinoma.

J A Bogart1, C Ungureanu, E Shihadeh, T C Chung, G A King, S Ryu, C Kent, J A Winfield.   

Abstract

We assessed a treatment plan of local therapy (resection and placement of permanent low dose-rate I-125 seeds) without whole brain irradiation in 15 patients with solitary brain metastasis (SBM) from primary non-small cell lung cancer between January, 1991 and May, 1996. Thirteen lesions were confirmed as solitary by MRI scan, and 2 patients had CT scan only. With median follow up of 14 months, 3 patients remain alive at 6, 33, and 62 months post-resection. Median survival is 14 months for all patients and 26 months for patients with SBM as the only site of disease. Five tumors failed in the brain: 2 solitary recurrences adjacent to the site of SBM, 2 multiple metastases outside the primary site, and 1 multiple recurrence including the primary site. No failures were seen with SBM <2.5 cm. Only 2 of 13 patients with SBM confirmed with MRI experienced relapses elsewhere in the brain. Recurrence rates both adjacent and outside the area of the initial brain lesion are similar to studies employing resection plus whole brain irradiation (WBI), and the patient is spared the acute and potential late toxicity of WBI. This approach may be considered for selected patients with solitary brain metastases (SBMs), although further experience with larger patient numbers is needed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582669     DOI: 10.1023/a:1006285304892

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  22 in total

1.  Dosimetry of I-125 seeds implanted on the surface of a cavity.

Authors:  S C Prasad; D A Bassano; P I Fear; G A King
Journal:  Med Dosim       Date:  1990-12       Impact factor: 1.482

Review 2.  Interstitial brachytherapy.

Authors:  M W McDermott; P H Gutin; D A Larson; P K Sneed
Journal:  Neurosurg Clin N Am       Date:  1990-10       Impact factor: 2.509

3.  Bronchogenic carcinoma with a brain metastasis: a continuing challenge.

Authors:  T A Salerno; J R Little; D D Munro
Journal:  Ann Thorac Surg       Date:  1979-03       Impact factor: 4.330

4.  Postoperative radiation for lung cancer metastatic to the brain.

Authors:  J G Armstrong; M Wronski; J Galicich; E Arbit; S A Leibel; M Burt
Journal:  J Clin Oncol       Date:  1994-11       Impact factor: 44.544

5.  Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group.

Authors:  A H Russell; T E Pajak; H M Selim; J C Paradelo; K Murray; P Bansal; J D Cooper; S Silverman; J A Clement
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-08       Impact factor: 7.038

6.  Surgery versus radiosurgery in the treatment of brain metastasis.

Authors:  A K Bindal; R K Bindal; K R Hess; A Shiu; S J Hassenbusch; W M Shi; R Sawaya
Journal:  J Neurosurg       Date:  1996-05       Impact factor: 5.115

7.  Interstitial iodine-125 radiosurgery for cerebral metastases.

Authors:  C B Ostertag; F W Kreth
Journal:  Br J Neurosurg       Date:  1995       Impact factor: 1.596

8.  The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

Authors:  E M Noordijk; C J Vecht; H Haaxma-Reiche; G W Padberg; J H Voormolen; F H Hoekstra; J T Tans; N Lambooij; J A Metsaars; A R Wattendorff
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-07-01       Impact factor: 7.038

9.  Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991.

Authors:  M Wroński; E Arbit; M Burt; J H Galicich
Journal:  J Neurosurg       Date:  1995-10       Impact factor: 5.115

10.  Distribution of brain metastases.

Authors:  J Y Delattre; G Krol; H T Thaler; J B Posner
Journal:  Arch Neurol       Date:  1988-07
View more
  19 in total

Review 1.  Radiotherapy and chemotherapy of brain metastases.

Authors:  R Soffietti; A Costanza; E Laguzzi; M Nobile; R Rudà
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

Review 2.  Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer.

Authors:  R Fuentes; X Bonfill; J Exposito
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

3.  Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.

Authors:  A Gabriella Wernicke; Menachem Z Yondorf; Luke Peng; Samuel Trichter; Lucy Nedialkova; Albert Sabbas; Fridon Kulidzhanov; Bhupesh Parashar; Dattatreyudu Nori; K S Clifford Chao; Paul Christos; Ilhami Kovanlikaya; Susan Pannullo; John A Boockvar; Philip E Stieg; Theodore H Schwartz
Journal:  J Neurosurg       Date:  2014-05-02       Impact factor: 5.115

4.  Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.

Authors:  A Gabriella Wernicke; Stefanie P Lazow; Shoshana Taube; Menachem Z Yondorf; Ilhami Kovanlikaya; Dattatreyudu Nori; Paul Christos; John A Boockvar; Susan Pannullo; Philip E Stieg; Theodore H Schwartz
Journal:  Oper Neurosurg (Hagerstown)       Date:  2015-08-01       Impact factor: 2.703

Review 5.  Controversies concerning the application of brachytherapy in central nervous system tumors.

Authors:  Bo-Lin Liu; Jin-Xiang Cheng; Xiang Zhang; Wei Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02       Impact factor: 4.553

6.  Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy.

Authors:  Michael J Petr; Christopher M McPherson; John C Breneman; Ronald E Warnick
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

7.  Changes in cell cycle, apoptosis and necrosis following the establishment of a (125)I brachytherapy model in the spinal cord in Banna mini-pigs.

Authors:  Zuozhang Yang; Congguo Jin; Ting Chen; Hongpu Sun; Dakuan Yang; Yunchao Huang; Jin Zhang; Ruilian Zhao; Jinlei Zhang
Journal:  Oncol Lett       Date:  2011-11-17       Impact factor: 2.967

Review 8.  Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.

Authors:  Rimas V Lukas; Maciej S Lesniak; Ravi Salgia
Journal:  CNS Oncol       Date:  2014-01

9.  Modern treatment of cerebral metastases: Integrated Medical Learning(SM) at CNS 2007.

Authors:  Michael A Vogelbaum; Anthony L Asher; Douglas Kondziolka; Nicholas M Boulis; Nathan R Selden; Brian L Hoh; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

10.  The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.

Authors:  Jeffrey J Olson; Nina A Paleologos; Laurie E Gaspar; Paula D Robinson; Rachel E Morris; Mario Ammirati; David W Andrews; Anthony L Asher; Stuart H Burri; Charles S Cobbs; Douglas Kondziolka; Mark E Linskey; Jay S Loeffler; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Roy A Patchell; Timothy C Ryken; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-03       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.